IDEXX Laboratories Inc

IDXX

NASDAQ. Currency in USD

402.17 -5.54 ( -1.36% )

Real time prices: December 19

Market Cap.
33.31B
Beta (5Y monthly)
1.19
Price/Earnings
54.45
EPS (TTM)
7.87
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
354,643
1y Target Est.
480.63
Day's Range
400.42
-
408.78
52 Week's Range
317.06
-
574.33

Historical Summary

Performance
EPS growth
Share Buybacks

About IDEXX Laboratories Inc

Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.idexx.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
84.79M
Employees
10000
Address
One IDEXX Drive, Westbrook, ME, United States, 04092
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Latest news

Here's Why You Should Invest in IDEXX (IDXX) Stock for Now
Here's Why You Should Invest in IDEXX (IDXX) Stock for Now

Investors are optimistic about IDEXX (IDXX) owing to strong international growth.
By Zacks Investment Research - 6 weeks ago

IDEXX (IDXX) CAG Sales Growth Strong, Costs Continue to Rise
IDEXX (IDXX) CAG Sales Growth Strong, Costs Continue to Rise

IDEXX's (IDXX) international revenues are primarily aided by gains in CAG and Water businesses.
By Zacks Investment Research - 6 weeks ago

Avanos Medical (AVNS) Up 21% Since Last Earnings Report: Can It Continue?
Avanos Medical (AVNS) Up 21% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take...
By Zacks Investment Research - 8 weeks ago

Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know
Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of IDEXX Laboratories (NASDAQ:IDXX) and lower...
By Benzinga - 10 weeks ago

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday

Gainers Abiomed, Inc. (NASDAQ: ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after...
By Benzinga - 12 weeks ago

Gartner, Sony, Uber And Other Big Gainers From Tuesday
Gartner, Sony, Uber And Other Big Gainers From Tuesday

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here...
By Benzinga - 12 weeks ago

IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down
IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down

IDEXX's (IDXX) Q3 top-line performance rides on strong CAG Diagnostics recurring revenue growth.
By Zacks Investment Research - 12 weeks ago